1. Home
  2. Live Updates
  3. Functional assessment

Live Breaking News & Updates on Functional assessment

Stay informed with the latest breaking news from Functional assessment on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Functional assessment and stay connected to the pulse of your community

Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy

Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.

United-states , American , Young , Massey-cancer-center , National-cancer-institute , Image-credit , Functional-assessment , Chronic-illness-therapy-fatigue , Edmonton-symptom-assessment-scale , American-journal , Managed-care

Iptacopan Demonstrates 38.3% Proteinuria Reduction in Patients With IgAN

Iptocopan demonstrated superiority when treating patients with immunoglobulin A nephropathy and is the first drug to specifically target the alternative complement pathway.

Argentina , Buenos-aires , Distrito-federal , David-soergel , Dana-rizk , Novartis-pharmaceuticals , University-of-alabama-at-birmingham , World-congress , Metabolism-development-unit , Novartis , Primary-iga-nephropathy-patients , Functional-assessment

AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab

AstraZeneca (AZN) Announces Voydeya Approval in EU as add-on to ravulizumab or eculizumab
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Japan , Marc-dunoyer , Hubert-schrezenmeier , Committee-for-medicinal-products-human , University-of-ulm , Drug-administration , European-medicines-agency , European-union , European-commission , Institute-of-transfusion-medicine , Medicinal-products

Single Question Can Predict Treatment Discontinuation in MM Patients

A single question can be used to predict early treatment discontinuation in patients with multiple myeloma, a study suggests. A single question can be used to predict early treatment discontinuation in patients with multiple myeloma, a study suggests.

Functional-assessment ,

Dactylitis, enthesitis resolution linked to less pain, fatigue in guselkumab-treated PsA

Dactylitis, enthesitis resolution linked to less pain, fatigue in guselkumab-treated PsA
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Canada , Newfoundland , Shenaz-bagha , Byjustin-cooper , Form-health-survey , Health-assessment-questionnaire , Memorial-university-of-newfoundland , Memorial-university , Leeds-enthesitis-index , Dactylitis-severity , Functional-assessment , Chronic-illness-therapy-fatigue

AstraZeneca's Voydeya approved in the US as add-on therapy for PNH patients with EVH

AstraZeneca's Voydeya (danicopan) has been approved in the US as add-on therapy for PNH patients with EVH. Find out more about this breakthrough treatment.

Japan , Facit , Lancashire , United-kingdom , Bart-scott , Marc-dunoyer , Alexion-pharmaceuticals-inc , Drug-administration , University-of-washington-medical-center , European-union , European-medicines-agency , Division-of-hematology

AstraZeneca : Voydeya approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular haemolysis in adults with the rare disease PNH - Form 6-K -April 02, 2024 at 08:48 am EDT

a9026i

FORM 6-K


SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


Report of Foreign Issuer


Pursuant to Rule 13a-16 or...

University-of-washington-medical-center , Washington , United-states , Boston , Massachusetts , Cambridge , Cambridgeshire , United-kingdom , Germany , Japan , Glasgow , Glasgow-city

AstraZeneca (AZN) announces Voydeya approved in the US

AstraZeneca (AZN) announces Voydeya approved in the US
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Japan , Marc-dunoyer , Bart-scott , European-union , University-of-washington-medical-center , European-medicines-agency , Division-of-hematology , Drug-administration , Lancet-haematology , Washington-medical-center , Clinical-research-division , Fred-hutchinson-cancer-center

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shiga , Japan , China , Cambridge , Cambridgeshire , United-kingdom , Boston , Massachusetts , United-states , Germany , Glasgow , Glasgow-city

Voydeya Approved as Add-On Therapy for Extravascular Hemolysis in PNH

The approval was based on data from the phase 3 ALPHA trial, which evaluated danicopan as add-on therapy to ravulizumab or eculizumab in adults with PNH and clinically significant EVH.

Marc-dunoyer , Drug-administration , Functional-assessment , Chronic-illness-therapy , Fatigue-score , Chief-executive-officer ,